ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TSHA Taysha Gene Therapies Inc

2.935
-0.035 (-1.18%)
Last Updated: 19:24:56
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0002.5M4.71M2.4M4.75M3.6M
Operating Income -49.27M-32.99M-25.07M-18.7M-16.56M-23.38M-15.63M-15.8M
Pre Tax Income -50.11M-33.87M-26.31M-55.72M-17.62M-24.6M-117.09M47.74M
Net Income -50.11M-33.87M-26.31M-55.72M-17.62M-24.6M-117.09M47.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -49.28M-32.99M-25.08M-18.71M-16.57M-23.38M-15.65M-15.82M
EBITDA -49.01M-32.71M-24.8M-18.34M-16.23M-23.04M-15.3M-15.43M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0002.5M15.45M
Operating Income -1.12M-43M-173.27M-126.03M-71.37M
Pre Tax Income -1.12M-60.01M-174.52M-166.01M-111.57M
Net Income -1.12M-60.01M-174.52M-166.01M-111.57M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.102-1.589-4.536-2.626-0.597
EBIT -1.12M-43M-173.27M-126.05M-71.42M
EBITDA -1.12M-42.99M-172.78M-124.86M-70M